A retrospective analysis of cardiovascular adverse events associated with immune checkpoint inhibitors

被引：0
作者：
Jessica Castrillon Lal
Sherry-Ann Brown
Patrick Collier
Feixiong Cheng
机构：
[1] Genomic Medicine Institute,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine
[2] Lerner Research Institute,Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Cleveland Clinic
[3] Cleveland Clinic,Case Comprehensive Cancer Center
[4] Case Western Reserve University,undefined
[5] Cardio-Oncology Program,undefined
[6] Division of Cardiovascular Medicine,undefined
[7] Medical College of Wisconsin,undefined
[8] Sydell and Arnold Miller Family Heart and Vascular Institute,undefined
[9] Case Western Reserve University School of Medicine,undefined
来源：
Cardio-Oncology | / 7卷
关键词：
Cardio-oncology; Cardiotoxicity; Immune checkpoint inhibitors; Immunotherapy; Myocardial infarction; Myocarditis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 372 条
  • [1] Schachter J(2017)Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006) Lancet 390 1853-1862
  • [2] Ribas A(2018)Nivolumab plus Ipilimumab versus Sunitinib in advanced renal-cell carcinoma N Engl J Med 378 1277-1290
  • [3] Long GV(2015)Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial Lancet Oncol 16 257-265
  • [4] Arance A(2020)Pharmacogenomics for immunotherapy and immune-related cardiotoxicity Hum Mol Genet 29 R186-R196
  • [5] Grob JJ(2020)Time to dissect the autoimmune etiology of cancer antibody immunotherapy J Clin Invest 130 51-61
  • [6] Mortier L(2020)Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis J ImmunoTher Cancer 8 2183-2193
  • [7] Daud A(2019)Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA Eur Heart J 41 1721-1728
  • [8] Carlino MS(2018)Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis JAMA Oncol 4 1579-1589
  • [9] McNeil C(2018)Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study Lancet Oncol 19 854-868
  • [10] Lotem M(2019)Cardiovascular toxicities associated with immune checkpoint inhibitors Cardiovasc Res 115 1749-1755
12345678910